NCT07112222 2026-01-26
A Study of LM-350 in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
Phase 1/2 Recruiting
Clinical Trials
10 trialsNCT05516914 2025-11-28
A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
NCT06942767 2025-04-27
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 2 Not yet recruiting
NCT04965077 2024-03-13
Treatment of Advanced and Metastatic Solid Tumors With MIL97
Beijing Mabworks Biotech Co., Ltd.
Phase 1 Recruiting
NCT04914117 2023-06-22
A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours
RemeGen Co., Ltd.
Phase 1 Completed
NCT02508441 2018-10-18
Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors
Andes Biotechnologies
Phase 1 Terminated
NCT01165905 2017-06-23
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
Traws Pharma, Inc.
Phase 1 Completed
NCT01837667 2017-01-24
Phase I Study of LB-100 With Docetaxel in Solid Tumors
Lixte Biotechnology Holdings, Inc.
Phase 1 Completed
NCT00088023 2014-03-31
Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
Spectrum Pharmaceuticals, Inc
Phase 1 Terminated
NCT00100139 2011-07-04
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer
INSYS Therapeutics Inc
Phase 1 Completed